Purple Biotech Sets September 8, 2026 AGM to Reshape Board Roles and Compensation PolicyTip Ranks·5 hours agoPPBT+0.73%
Purple Biotech Updates Investors on CAPTN-3 Platform and Pipeline as IM1240 Nears 2027 Clinic EntryTip Ranks·Jun 23 at 09:49 AMPPBT+0.73%
U.S. stock night market fluctuations: Aplite rose 3.10% with net inflow from main funds, and biotech stocks slightly increasedPrice Alert·Jun 12 at 02:46 AMPPBT+0.73%
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga_article·Jun 11 at 12:05 PMGELS-1.93%ADIL+6.78%
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga_article·Jun 11 at 07:05 AMPPCB-18.18%PPBT+0.73%
Purple Biotech shares are trading higher after the company announced the presentation of new preclinical data from its lead CAPTN-3 program, IM1240, at EACR 2026 Annual Congress.benzinga_article·Jun 11 at 06:17 AMPPBT+0.73%
Purple Biotech Q1 2026 Results Highlight CAPTN-3 Pivot and IM1240 Preclinical MomentumTip Ranks·May 15 at 06:28 AMPPBT+0.73%
Purple Biotech Reports First Quarter 2026 Financial Results and Business Highlights | PPBT Stock NewsStockTitan·May 14 at 10:00 PMPPBT+0.73%
Pre-market hot trades in US stocks: Purple Biotech up 7.23% in pre-market; Abits up 7.17% in pre-marketPrice Alert·Apr 20 at 04:32 AMPPBT+0.73%ABTS-9.57%
Patent Cliff Risk: How Expiring Protections Threaten Purple Biotech’s Future Exclusivity and ReturnsTip Ranks·Mar 20 at 01:01 AMPPBT+0.73%
US Stock Movement Update: Arcellx surged 77.55%, Signing Day Sports rose 54.44%, Blue Hat Interactive Ent Tech fell 46.28%Price Alert·Feb 23 at 01:00 PMACLX0.00%SGN0.00%
